[1]
|
Das, J. and Rajanikant, G.K. (2018) Post Stroke Depression: The Sequelae of Cerebral Stroke. Neuroscience and Biobe-havioral Reviews, 90, 104-114. https://doi.org/10.1016/j.neubiorev.2018.04.005
|
[2]
|
Jeong, Y.J., Kim, W.C., Kim, Y.S., Choi, K.W., Son, S.Y. and Jeong, Y.G. (2014) The Relationship between Rehabilitation and Changes in Depres-sion in Stroke Patients. The Journal of Physical Therapy Science, 26, 1263-1266.
https://doi.org/10.1589/jpts.26.1263
|
[3]
|
Mitchell, A.J., Sheth, B., Gill, J., Yadegarfar, M., Stubbs, B., Yadegarfar, M. and Meader, N. (2017) Prevalence and Predictors of Post-Stroke Mood Disorders: A Meta-Analysis and Me-ta-Regression of Depression, Anxiety and Adjustment Disorder. General Hospital Psychiatry, 47, 48-60. https://doi.org/10.1016/j.genhosppsych.2017.04.001
|
[4]
|
齐士魁, 高静, 余明月, 等. 脑卒中后抑郁发病机制的研究进展[J]. 卒中与神经疾病, 2022, 29(5): 483-486.
|
[5]
|
Gutiérrez-Muto, A.M., Castilla, J., Freire, M., et al. (2020) Theta Burst Stimulation: Technical Aspects about TMS Devices. Brain Stimulation, 13, 562-564. https://doi.org/10.1016/j.brs.2020.01.002
|
[6]
|
Tripathi, S.M., Mishra, N., Tripathi, R.K., et al. (2015) P300 Laten-cy as an Indicator of Severity in Major Depressive Disorder. Industrial Psychiatry Journal, 24, 163-167. https://doi.org/10.4103/0972-6748.181726
|
[7]
|
Nan, C., Wang, G., Wang, H., et al. (2018) The P300 Component Decreases in a Bimodal Oddball Task in Individuals with Depression: An Event-Related Potentials Study. Clinical Neu-rophysiology: Official Journal of the International Federation of Clinical Neurophysiology, 129, 2525-2533. https://doi.org/10.1016/j.clinph.2018.09.012
|
[8]
|
Zhou, L., Wang, G. and Wang, H. (2018) Abnormalities of P300 before and after Antidepressant Treatment in Depression: An ERP-sLORETA Study. NeuroReport, 29, 160-168. https://doi.org/10.1097/WNR.0000000000000945
|
[9]
|
Oberman, L.M. and Pascual-Leone, A. (2009) Report of Seizure Induced by Continuous Theta Burst Stimulation. Brain Stimulation, 2, 246-247. https://doi.org/10.1016/j.brs.2009.03.003
|
[10]
|
Rossi, S., Antal, A., Bestmann, S., et al. (2021) Safety and Recom-mendations for TMS Use in Healthy Subjects and Patient Populations, with Updates on Training, Ethical and Regulatory Issues: Expert Guidelines. Clinical Neurophysiology, 132, 269-306. https://doi.org/10.1016/j.clinph.2020.10.003
|
[11]
|
Van de Weg, F.B., Kuik, D.J. and Lankhorst, G.J. (1999) Post-Stroke Depression and Functional Outcome: A Cohort Study Investigating the Influence of Depression on Func-tional Recovery from Stroke. Clinical Rehabilitation, 13, 268- 272. https://doi.org/10.1191/026921599672495022
|
[12]
|
Swartz, R.H., Bayley, M., Lanctot, K.L., Murray, B.J., Cayley, M.L., Lien, K., et al. (2016) Post-Stroke Depression, Obstructive Sleep Apnea, and Cognitive Impairment: Rationale for, and Barriers to, Routine Screening. International Journal of Stroke, 11, 509-518. https://doi.org/10.1177/1747493016641968
|
[13]
|
Trivedi, M.H., Rush, A.J., Wisniewski, S.R., Nierenberg, A.A., Warden, D., Ritz, L., Norquist, G., Howland, R.H., Lebowitz, B., McGrath, P.J., Shores-Wilson, K., Biggs, M.M., Bal-asubramani, G.K. and Fava, M. (2006) Evaluation of Outcomes with Citalopram for Depression Using Measure-ment-Based Care in STAR*D: Implications for Clinical Practice. The American Journal of Psychiatry, 163, 28-40. https://doi.org/10.1176/appi.ajp.163.1.28
|
[14]
|
Juang, H.T., Chen, P.C. and Chien, K.L. (2015) Using Antidepres-sants and the Risk of Stroke Recurrence: Report from a National Representative Cohort Study. BMC Neurology, 15, Ar-ticle No. 86.
https://doi.org/10.1186/s12883-015-0345-x
|
[15]
|
Richter, D., Charles James, J., Ebert, A., Katsanos, A.H., Ma-zul-Wach, L., Ruland, Q., Gold, R., Juckel, G. and Krogias, C. (2021) Selective Serotonin Reuptake Inhibitors for the Prevention of Post-Stroke Depression: A Systematic Review and Meta-Analysis. Journal of Clinical Medicine, 10, Arti-cle No. 5912. https://doi.org/10.3390/jcm10245912
|
[16]
|
Hordacre, B., Comacchio, K., Williams, L. and Hillier, S. (2021) Repetitive Transcranial Magnetic Stimulation for Post-Stroke Depression: A Randomised Trial with Neurophysi-ological Insight. Journal of Neurology, 268, 1474-1484.
https://doi.org/10.1007/s00415-020-10315-6
|
[17]
|
Tomeh, A., Yusof Khan, A.H.K. and Wan Sulaiman, W.A. (2022) Repetitive Transcranial Magnetic Stimulation of the Primary Motor Cortex in Stroke Survivors—More than Mo-tor Rehabilitation: A Mini-Review. Frontiers in Aging Neuroscience, 14, Article ID: 897837. https://doi.org/10.3389/fnagi.2022.897837
|
[18]
|
Huang, Y.Z., Rothwell, J.C., Lu, C.S., Wang, J., et al. (2009) The Effect of Continuous Theta Burst Stimulation over Premotor Cortex on Circuits in Primary Motor Cortex and Spinal Cord. Clinical Neurophysiology, 120, 796-801.
https://doi.org/10.1016/j.clinph.2009.01.003
|
[19]
|
Chistyakov, A.V., Rubicsek, O., Kaplan, B., Zaaroor, M. and Klein, E. (2010) Safety, Tolerability and Preliminary Evidence for Antidepressant Efficacy of Theta-Burst Transcranial Magnetic Stimulation in Patients with Major Depression. International Journal of Neuropsychopharmacology, 13, 387-393.
https://doi.org/10.1017/S1461145710000027
|
[20]
|
Holzer, M. and Padberg, F. (2010) Intermittent Theta-Burst Stimulation (iTBS) Ameliorates Therapy Resistant Depression: A Case Series. Brain Stimulation, 3, 181-183. https://doi.org/10.1016/j.brs.2009.10.004
|
[21]
|
Li, C.T., Chen, M.H., Juan, C.H., et al. (2014) Efficacy of Prefrontal Theta-Burst Stimulation in Refractory Depression: A Randomized Sham-Controlled Study. Brain, 137, 2088-2098. https://doi.org/10.1093/brain/awu109
|
[22]
|
O’Reardon, J.P., Solvason, H.B., Janicak, P.G., et al. (2007) Efficacy and Safety of Transcranial Magnetic Stimulation in the Acute Treatment of Major Depression: A Multisite Randomized Controlled Trial. Biological Psychiatry, 62, 1208-1216. https://doi.org/10.1016/j.biopsych.2007.01.018
|
[23]
|
Blumberger, D.M., Vila-Rodriguez, F., Thorpe, K.E., et al. (2018) Effectiveness of Theta-Burst versus High-Fre- quency Repetitive Transcranial Magnetic Stimulation in Patients with Depression (THREE-D): A Randomised Non- Inferiority Trial. The Lancet, 391, 1683-1692. https://doi.org/10.1016/S0140-6736(18)30295-2
|